These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis]. Volpi A, Cavalli A, Maggioni AP, Inglese E, Rovelli GE, Neri R, Salvi A. G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892 [Abstract] [Full Text] [Related]
23. A case of disappearing amyloid on technetium pyrophosphate scan. Wang A, Mahmood U, Tang X, Jain D, Pan S. J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232 [Abstract] [Full Text] [Related]
25. Alternative Isotope Options for Amyloidosis Imaging: A Technologist's Perspective. Warren J. J Nucl Med Technol; 2023 Jun; 51(2):117-119. PubMed ID: 37192821 [Abstract] [Full Text] [Related]
26. [Echography and scintigraphy using technetium 99m pyrophosphate in the diagnosis of cardiac amyloidosis]. Guy JM, Lamaud M, Segura C, Berthaud T, Duranton B, Verneyre H. Ann Cardiol Angeiol (Paris); 1989 Apr; 38(4):215-8. PubMed ID: 2544133 [Abstract] [Full Text] [Related]
29. Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis. Falk RH, Lee VW, Rubinow A, Skinner M, Cohen AS. Am J Cardiol; 1984 Nov 01; 54(8):1150-1. PubMed ID: 6093493 [No Abstract] [Full Text] [Related]
30. Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi. Ochi Y, Kubo T, Baba Y, Ueda M, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Kitaoka H. J Cardiol; 2021 Feb 01; 77(2):124-130. PubMed ID: 33132078 [Abstract] [Full Text] [Related]
31. Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy. Hongo M, Hirayama J, Fujii T, Yamada H, Okubo S, Kusama S, Ikeda S. Am Heart J; 1987 Mar 01; 113(3):654-62. PubMed ID: 3030086 [Abstract] [Full Text] [Related]
32. Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis. Castaño A, DeLuca A, Weinberg R, Pozniakoff T, Blaner WS, Pirmohamed A, Bettencourt B, Gollob J, Karsten V, Vest JA, Chiuzan C, Maurer MS, Bokhari S. J Nucl Cardiol; 2016 Dec 01; 23(6):1355-1363. PubMed ID: 26453570 [Abstract] [Full Text] [Related]
33. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with 99m Technetium Pyrophosphate Planar Imaging and Opportunities for Standardization of Diagnostic Workflow. Saleem M, Sadat B, Van Harn M, Ananthasubramaniam K. Medicina (Kaunas); 2023 Feb 16; 59(2):. PubMed ID: 36837580 [Abstract] [Full Text] [Related]
34. Comparison of Tc-99m pyrosphosphate and Tc-99m hydroxymethylene diphosphonate in acute myocardial infarction: concise communication. Wakat MA, Chilton HM, Hackshaw BT, Cowan RJ, Ball JD, Watson NE. J Nucl Med; 1980 Mar 16; 21(3):203-6. PubMed ID: 6245193 [Abstract] [Full Text] [Related]
35. Myocardial Tc-99m MDP uptake on a bone scan in senile systemic amyloidosis with cardiac involvement. Ak I, Vardareli E, Erdinĉ O, Kasapoğlu E, Ata N. Clin Nucl Med; 2000 Oct 16; 25(10):826-7. PubMed ID: 11043729 [No Abstract] [Full Text] [Related]
36. Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis. Takahashi K, Hiratsuka Y, Iwamura T, Sasaki D, Yamamura N, Kitazawa S, Ueda M, Morioka H, Okura T, Enomoto D, Uemura S, Kono T, Sakaue T, Ikeda S. Amyloid; 2024 Mar 16; 31(1):12-21. PubMed ID: 37486102 [Abstract] [Full Text] [Related]
37. Interobserver variability in the interpretation of myocardial images with Tc-99m-labeled diphosphonate and pyrophosphate. Cuarón A, Acero AP, Cárdenas M, Huerta D, Rodríguez A, de Garay R. J Nucl Med; 1980 Jan 16; 21(1):1-9. PubMed ID: 6243350 [No Abstract] [Full Text] [Related]
38. Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases. Chan N, Einstein AJ, Griffin JM, Rosenblum H, Teruya S, Cuomo M, De Los Santos J, DeLuca A, Johnson LL, Kinkhabwala MP, Leb JS, Mintz A, Fine D, Helmke S, Muralidhar V, Pandey S, Sabogal N, Saith SE, Winburn M, Smiley D, Miller EJ, Ruberg FL, Maurer MS. J Nucl Cardiol; 2023 Dec 16; 30(6):2531-2539. PubMed ID: 37311914 [Abstract] [Full Text] [Related]
39. Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate in acute myocardial infarction: concise communication. Kelly RJ, Chilton H, Hackshaw BT, Ball JD, Watson NE, Kahl FR, Cowan FJ. J Nucl Med; 1979 May 16; 20(5):402-6. PubMed ID: 232147 [Abstract] [Full Text] [Related]
40. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution. Poterucha TJ, Elias P, Bokhari S, Einstein AJ, DeLuca A, Kinkhabwala M, Johnson LL, Flaherty KR, Saith SE, Griffin JM, Perotte A, Maurer MS. JACC Cardiovasc Imaging; 2021 Jun 16; 14(6):1221-1231. PubMed ID: 33221204 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]